FLEX: A Real-World Evidence, Full Transcriptome Study in 30,000 Patients With Early-Stage Breast Cancer
Title: FLEX: A Real-World Evidence, Full Transcriptome Study in 30,000 Read More
MammaPrint and BluePrint Predict Pathological Response to Neoadjuvant Chemotherapy in Patients With HR+HER2- Early-Stage Breast Cancer Enrolled in FLEX
Title: MammaPrint® and BluePrint® Predict Pathological Response to Neoadjuvant Read More
Neoadjuvant Chemotherapy for T3 tumors in the Era of Precision Medicine- Biology is Still King
Title: Neoadjuvant Chemotherapy for T3 tumors in the Era Read More
Prediction of Chemotherapy Benefit by MammaPrint in HR+HER2- Early Stage Breast Cancer Revealed by the FLEX Registry of Real World Data
Title: Prediction of Chemotherapy Benefit by MammaPrint® in HR+HER2- Read More
Association of MammaPrint With Gene Expression Pathways Predictive of Resistance to Cyclin-Dependent Kinase Inhibition
Title: Association of MammaPrint® With Gene Expression Pathways Predictive Read More
Differential Long-Term Benefit of 2-Year Adjuvant Tamoxifen Therapy for Luminal-Type Breast Cancer: Insights From a 20-Year Follow-Up Analysis of the STO Trials
Title: Differential long-term benefit of 2-year adjuvant tamoxifen therapy Read More
Selection of Patients With Early-Stage Breast Cancer for Extended Endocrine Therapy: A Secondary Analysis of the IDEAL Randomized Clinical Trial
Title: Selection of Patients With Early-Stage Breast Cancer for Read More
Incorporating Immunotherapy in the Management of Early-Stage Estrogen Receptor-Positive Breast Cancer
Title: Incorporating immunotherapy in the management of early-stage estrogen Read More
Hormone Receptor Positive HER2-negative/MammaPrint High-2 Breast Cancers Closely Resemble Triple Negative Breast Cancers
Title: Hormone Receptor Positive HER2-negative/MammaPrint High-2 Breast Cancers Closely Read More
70‑Gene signature‑guided adjuvant systemic treatment adjustments in early‑stage ER+ breast cancer patients: 7‑year follow‑up study
Title: 70‑Gene signature‑guided adjuvant systemic treatment adjustments in early‑stage Read More
